GHK-Cu vs MGF (Mechano Growth Factor)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

GHK-CuMGF (Mechano Growth Factor)
CategoryGrowth FactorsGrowth Factors
Standard DoseResearch indicates 1-2 mg daily via subcutaneous injection, or topical application at 1-3% concentration in cream/serum.Research indicates 100-200 mcg per injection site, administered bilaterally into target muscles immediately post-workout.
TimingEvening administration preferred for skin rejuvenation (aligns with nocturnal repair cycles). Topical can be applied morning and evening.Immediately post-workout (within 5-10 minutes) for optimal satellite cell activation. Must be injected directly into the trained muscle.
Cycle Duration8-12 weeks for injectable cycles. Topical use can be ongoing.4-6 week cycles.
Evidence Levelmoderate_humananimal_plus_anecdotal
A

GHK-Cu

Growth Factors

Mechanism

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that modulates gene expression affecting 31.2% of human genes. It activates Wnt/beta-catenin signaling for hair follicle growth, stimulates TGF-beta pathway for tissue remodeling, and promotes collagen and glycosaminoglycan synthesis while modulating metalloproteinase activity. The copper ion serves as a cofactor for enzymes essential to wound healing including superoxide dismutase and lysyl oxidase.

Standard Dosing

Research indicates 1-2 mg daily via subcutaneous injection, or topical application at 1-3% concentration in cream/serum.

Timing

Evening administration preferred for skin rejuvenation (aligns with nocturnal repair cycles). Topical can be applied morning and evening.

Cycle Duration

8-12 weeks for injectable cycles. Topical use can be ongoing.

Side Effects

  • Injection site redness
  • Mild stinging with topical application
  • Transient skin warmth

Contraindications

  • Wilson's disease or copper metabolism disorders
  • Liver disease
  • Pregnancy and breastfeeding
  • Use caution with copper-overload states

Best Stacking Partners

EpitalonBPC-157TB-500Thymosin Alpha-1

Mechanism

MGF is the E domain peptide of the IGF-1Ec splice variant, produced when the IGF-1 gene is mechanically spliced in response to muscle damage or exercise. It activates satellite cells (muscle stem cells), promoting their proliferation and preventing premature differentiation. After exercise/injury, IGF-1 gene is first spliced toward MGF (proliferation phase) then shifts to IGF-1Ea (differentiation phase). MGF uniquely drives the initial proliferative response, expanding the pool of myogenic precursor cells before they fuse with existing muscle fibers.

Standard Dosing

Research indicates 100-200 mcg per injection site, administered bilaterally into target muscles immediately post-workout.

Timing

Immediately post-workout (within 5-10 minutes) for optimal satellite cell activation. Must be injected directly into the trained muscle.

Cycle Duration

4-6 week cycles.

Side Effects

  • Injection site pain/swelling
  • Hypoglycemia (less than IGF-1 LR3)
  • Localized inflammation

Contraindications

  • Active cancer
  • Pregnancy and breastfeeding
  • Under 25 years of age

Best Stacking Partners

PEG-MGFIGF-1 LR3HGH

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →